Key result
Higher fatty liver index linked to ~27% greater odds of ischemic heart disease per SD.
Why the study?
Non-alcoholic fatty liver disease contributes to ischemic heart disease development, and the value of fatty liver index to detect prevalent IHD in the general population was unclear.
Is the fatty liver index (FLI) associated with prevalent ischemic heart disease and does it improve detection over conventional risk factors in the general population?
Cross-Sectional (n=32,938)
Is the fatty liver index (FLI) associated with prevalent ischemic heart disease and does it improve detection over conventional risk factors in the general population?
Odds Ratio: 1.27 (95% CI 1.106–1.458)
p-value: p=0.001
The fatty liver index is positively and linearly associated with prevalent ischemic heart disease and provides incremental value over conventional risk factors for detecting IHD in the general population.
May aid IHD detection beyond conventional risks; hypothesis-generating and requires prospective validation.
Background Non-alcoholic fatty liver disease (NAFLD) contributes to the development of ischemic heart disease via multiple mechanisms. Fatty liver index (FLI) has been proposed as an accurate, convenient, and economic surrogate of the severity of NAFLD. Our present study aims to assess the association between FLI and the prevalent IHD and to evaluate the potential value of FLI to refine the detection of prevalent IHD in the general population. Methods Our work recruited 32,938 subjects from the National Health and Nutrition Examination Survey 1999–2016. IHD was diagnosed according to the subjects’ self-report. FLI was determined based on triglycerides, BMI, γ-glutamyltransferase, and waist circumference. Results 2,370 (7.20%) subjects were diagnosed with IHD. After adjustment of age, sex, race, current smoking, current drinking, PIR, BMI, WC, TC, TG, GGT, Scr, FPG, SBP, anti-hypertensive therapy, anti-diabetic therapy, and lipid-lowering therapy, one standard deviation increase of FLI resulted in a 27.0% increment of the risk of prevalent IHD. In the quartile analysis, we observed a 1.684 times risk of prevalent IHD when comparing the fourth quartile with the first quartile, and there was a trend towards higher risk across the quartiles. The smooth curve fitting displayed a linear relationship between FLI and the presence of IHD without any threshold or saturation effect. Subgroup analysis revealed a robust association in conventional cardiovascular subpopulations, and the association could be more prominent in female subjects and diabetes patients. ROC analysis demonstrated an incremental value of FLI for detecting prevalent IHD after introducing it to conventional cardiovascular risk factors (AUC: 0.823 vs. 0.859, P for comparison <0.001). Also, results from reclassification analysis implicated that more IHD patients could be correctly identified by introducing FLI into conventional cardiovascular risk factors (continuous net reclassification index: 0.633, P < 0.001; integrated discrimination index: 0.034, P < 0.001). Conclusion The current analysis revealed a positive and linear relationship between FLI and the prevalent IHD. Furthermore, our findings suggest the incremental value of FLI to refine the detection of prevalent IHD in the general population.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2023) conducted a cross-sectional in Ischemic Heart Disease (n=32,938). Fatty liver index (FLI) vs. Lower FLI (per 1 SD increase) was evaluated on Prevalent ischemic heart disease (IHD) (OR 1.270, 95% CI 1.106-1.458, p=0.001). Each one standard deviation increase in the fatty liver index was independently associated with a 27.0% higher odds of prevalent ischemic heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: